Sandra Barrow, MD
Nephrology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 20 years
- Graduated 2006
Offices
1 location · Nephrology Associates · 7 clinicians in this group
Looking this up.
Hospitals listed: 052887 · 552550 · 552566 · 552730 · Adventist Health Mendocino Coast · Adventist Health Ukiah Valley · Providence Santa Rosa Memorial Hospital · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barrow’s office at (707) 526-2027 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C157688 · Current
Licensed to practise in California · since 2018 · expires 2028-08-31 · Georg-August-University of Gottingen Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas P8761Physician License · since 2014 · expires 2027-02-28ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$262,535
Medicare paid this office $262,535 for 475 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 75 | $139,186 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $45,351 | $90 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $18,782 | $163 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $13,185 | $216 |
| Return visit (30+ min) | 165 | $12,053 | $53 |
See all 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 75 | $139,186 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $45,351 | $90 |
| Dialysis services, 1 physician visit per month (20 years or older) | 34 | $18,782 | $163 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $13,185 | $216 |
| Return visit (30+ min) | 165 | $12,053 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $11,759 | $129 |
| Critical care, first 30-74 minutes | 32 | $8,900 | $159 |
| Home dialysis services per month (20 years or older) | 12 | $8,086 | $225 |
| Long return visit (40+ min) | 20 | $2,463 | $112 |
| New patient visit (45+ min) | 12 | $1,066 | $89 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $808 | $24 |
Who their Medicare patients are
475 Original Medicare patients in 2024. Average age 74 · Under 65 18% · 85 and older 16% · Women 45% · Also on Medicaid 42% · Health risk score 4.85. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 58% · Heart failure 52% · Coronary heart disease 46% · Atrial fibrillation 39% · Depression 28% · COPD 23% · Cancer 21% · Stroke 17% · Dementia 11%.
The office billed $512,550, Medicare allowed $345,652 and paid $262,535; for 1,670 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 475 | 1,670 | 74 | 4.85 | $512,550 | $262,535 |
| 2023 | 512 | 1,666 | 74 | 4.29 | $443,501 | $267,080 |
| 2022 | 537 | 1,740 | 74 | 3.71 | $420,852 | $253,495 |
| 2021 | 594 | 1,752 | 74 | 3.81 | $439,959 | $269,610 |
| 2020 | 524 | 1,767 | 72 | 4.34 | $400,703 | $244,962 |
| 2019 | 515 | 2,041 | 71 | 4.30 | $372,822 | $225,459 |
| 2018 | 620 | 2,585 | 64 | 4.79 | $385,072 | $162,250 |
| 2017 | 561 | 3,451 | 62 | 5.10 | $547,052 | $197,792 |
| 2016 | 594 | 3,654 | 62 | 5.12 | $596,592 | $216,166 |
| 2015 | 541 | 2,802 | 61 | 5.05 | $458,076 | $168,771 |
| 2014 | 229 | 728 | 59 | 5.20 | $119,853 | $47,666 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $79,527 | $259 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $45,770 | $303 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 175 | $44,713 | $100 |
| Home dialysis services per month (20 years or older) | 16 | $29,707 | $261 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $20,827 | $180 |
| Return visit (30+ min) | 194 | $19,342 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $13,724 | $146 |
| Critical care, first 30-74 minutes | 21 | $6,440 | $179 |
| Long return visit (40+ min) | 17 | $2,050 | $98 |
| New patient visit (45+ min) | 14 | $1,898 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 40 | $1,257 | $28 |
| Short return visit (20+ min) | 15 | $537 | $34 |
2022: 12 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 51 | $86,922 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 168 | $44,891 | $86 |
| Home dialysis services per month (20 years or older) | 14 | $30,558 | $261 |
| Return visit (30+ min) | 215 | $29,330 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $14,334 | $158 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $12,541 | $172 |
| Critical care, first 30-74 minutes | 22 | $9,049 | $185 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $8,514 | $294 |
| Long return visit (40+ min) | 34 | $7,594 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 72 | $3,808 | $45 |
| Short return visit (20+ min) | 18 | $1,370 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $870 | $54 |
2021: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 71 | $67,643 | $252 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $53,110 | $302 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 195 | $48,984 | $87 |
| Return visit (30+ min) | 160 | $21,102 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $18,866 | $163 |
| Home dialysis services per month (20 years or older) | 13 | $17,120 | $259 |
| New patient visit (45+ min) | 112 | $14,948 | $133 |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $7,422 | $177 |
| Critical care, first 30-74 minutes | 22 | $7,229 | $181 |
| Long return visit (40+ min) | 23 | $4,119 | $153 |
| Telephone medical discussion with physician, 11-20 minutes | 61 | $3,174 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,949 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $890 | $64 |
2020: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 74 | $73,387 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $50,897 | $89 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 72 | $36,978 | $203 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $21,575 | $166 |
| Return visit (30+ min) | 140 | $15,621 | $81 |
| Critical care, first 30-74 minutes | 33 | $13,389 | $189 |
| New patient visit (45+ min) | 75 | $9,299 | $124 |
| Dialysis services, 1 physician visit per month (20 years or older) | 42 | $8,243 | $162 |
| Telephone medical discussion with physician, 11-20 minutes | 77 | $3,800 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,114 | $62 |
| Hemodialysis procedure with physician evaluation | 15 | $944 | $59 |
2019: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 53 | $61,272 | $233 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $45,220 | $85 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 63 | $35,383 | $195 |
| Return visit (30+ min) | 142 | $17,866 | $82 |
| New patient visit (45+ min) | 150 | $17,257 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,660 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $8,703 | $60 |
| Critical care, first 30-74 minutes | 24 | $7,231 | $181 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,484 | $102 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $4,313 | $154 |
| Hemodialysis procedure with physician evaluation | 30 | $2,469 | $60 |
2018: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 231 | $62,890 | $56 |
| Return visit (30+ min) | 173 | $24,131 | $80 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 72 | $21,497 | $205 |
| New patient visit (45+ min) | 90 | $11,604 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $7,968 | $77 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 20 | $5,953 | $186 |
| Hemodialysis procedure with physician evaluation | 59 | $5,634 | $56 |
| Short return visit (20+ min) | 78 | $5,029 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $4,941 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,187 | $108 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,085 | $30 |
| Hospital discharge day management, 30 minutes or less | 13 | $919 | $57 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 367 | $122,441 | $53 |
| Return visit (30+ min) | 190 | $31,783 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $13,302 | $76 |
| Hemodialysis procedure with physician evaluation | 99 | $11,120 | $54 |
| Short return visit (20+ min) | 111 | $7,244 | $46 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,303 | $154 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,537 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 51 | $1,664 | $28 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 357 | $125,268 | $54 |
| Return visit (30+ min) | 198 | $39,512 | $76 |
| Hemodialysis procedure with physician evaluation | 124 | $16,759 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $13,470 | $80 |
| Short return visit (20+ min) | 127 | $9,665 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,216 | $153 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 51 | $1,926 | $30 |
| Return visit (30+ min) | 14 | $770 | $55 |
2015: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 314 | $92,047 | $58 |
| Return visit (30+ min) | 213 | $28,759 | $76 |
| Hemodialysis procedure with physician evaluation | 102 | $14,857 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $9,511 | $80 |
| Short return visit (20+ min) | 115 | $8,681 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 96 | $5,164 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,766 | $163 |
| Return visit (30+ min) | 25 | $1,507 | $58 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $23,109 | $57 |
| Return visit (30+ min) | 99 | $11,654 | $85 |
| Hemodialysis procedure with physician evaluation | 33 | $3,600 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,544 | $82 |
| Short return visit (20+ min) | 36 | $2,364 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $374 | $31 |
Medicaid work
$68,207 in 2024
Medicaid paid $68,207 for 899 billed services this clinician did in 2024, up to 56 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 407 | $48,441 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 419 | $11,887 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 49 | $6,230 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 12 | $970 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $680 |
| 2024 | 899 | 5 | 56 | $68,207 |
| 2023 | 1,164 | 6 | 34 | $81,716 |
| 2022 | 974 | 4 | 37 | $67,519 |
| 2021 | 915 | 5 | 43 | $49,619 |
| 2020 | 930 | 5 | 34 | $56,765 |
| 2019 | 139 | 5 | 27 | $9,118 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 413 | $47,290 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 528 | $18,027 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 94 | $9,849 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 24 | $2,592 |
| 1ST HOSP IP/OBS HIGH 75 | 33 | $2,019 |
| Return visit (30+ min) | 72 | $1,940 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 429 | $50,219 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 477 | $15,047 |
| Return visit (30+ min) | 55 | $1,485 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $769 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 266 | $24,416 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 499 | $12,417 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 118 | $11,757 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 14 | $669 |
| Return visit (30+ min) | 18 | $360 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 245 | $28,126 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 124 | $12,961 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 501 | $12,423 |
| 1ST HOSP IP/OBS HIGH 75 | 40 | $1,861 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 20 | $1,393 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 53 | $6,184 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 45 | $989 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 16 | $898 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $577 |
| Return visit (30+ min) | 13 | $470 |
Drugs they prescribed that Part D paid
$270,388
Pharmacies billed $270,388 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,098) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
872 generic and 226 brand-name prescriptions · $270,388 in drug cost · 46 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 73 | $103,065 | $1,412 |
| Veltassa | 28 | $46,556 | $1,663 |
| Lanthanum Carbonate | 27 | $20,198 | $748 |
| Sevelamer Carbonate | 62 | $18,680 | $301 |
| Farxiga | 22 | $13,600 | $618 |
See all 26 drugs
| Jardiance | 73 | $103,065 | $1,412 |
| Veltassa | 28 | $46,556 | $1,663 |
| Lanthanum Carbonate | 27 | $20,198 | $748 |
| Sevelamer Carbonate | 62 | $18,680 | $301 |
| Farxiga | 22 | $13,600 | $618 |
| Dapagliflozin | 15 | $7,420 | $495 |
| Prosol | 49 | $6,778 | $138 |
| Calcitriol | 59 | $1,379 | $23 |
| Calcium Acetate | 29 | $1,365 | $47 |
| Bumetanide | 24 | $1,355 | $56 |
| Hydralazine | 85 | $1,257 | $15 |
| Amlodipine Besylate | 98 | $933 | $10 |
| Losartan | 61 | $793 | $13 |
| Nifedipine Er | 14 | $707 | $51 |
| Midodrine | 22 | $669 | $30 |
| Furosemide | 87 | $641 | $7 |
| Metolazone | 19 | $584 | $31 |
| Allopurinol | 15 | $403 | $27 |
| Potassium Chloride | 18 | $342 | $19 |
| Clonidine | 22 | $337 | $15 |
| Carvedilol | 32 | $332 | $10 |
| Lidocaine-Prilocaine | 13 | $319 | $25 |
| Ciprofloxacin | 31 | $126 | $4 |
| Hydrochlorothiazide | 11 | $91 | $8 |
| Lisinopril | 18 | $29 | $2 |
| Cephalexin | 12 | $28 | $2 |
Year by year
| 2024 | 1,098 | 220 | 0% (0) | 21% | $270,388 |
| 2023 | 909 | 216 | 0% (0) | 13% | $167,553 |
| 2022 | 1,024 | 241 | 0% (0) | 9% | $194,228 |
| 2021 | 892 | 223 | 0% (0) | 13% | $295,554 |
| 2020 | 1,038 | 219 | None | None | $100,677 |
| 2019 | 1,193 | 263 | None | None | $118,974 |
| 2018 | 1,423 | 196 | 1% (15) | 9% | $215,918 |
| 2017 | 1,686 | 157 | 2% (28) | 6% | $241,023 |
| 2016 | 1,034 | 124 | 2% (25) | None | $216,687 |
| 2015 | 502 | 86 | 4% (20) | None | $87,230 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Veltassa | 22 | $31,180 | $1,417 |
| Jardiance | 13 | $24,735 | $1,903 |
| Lanthanum Carbonate | 18 | $19,988 | $1,110 |
| Sevelamer Carbonate | 59 | $18,646 | $316 |
| Calcium Acetate | 20 | $4,020 | $201 |
| Bumetanide | 17 | $2,940 | $173 |
| Hydralazine | 97 | $2,712 | $28 |
| Calcitriol | 58 | $1,623 | $28 |
| Metolazone | 11 | $1,533 | $139 |
| Midodrine | 21 | $1,454 | $69 |
| Amlodipine Besylate | 98 | $1,334 | $14 |
| Nifedipine Er | 17 | $1,213 | $71 |
| Furosemide | 104 | $963 | $9 |
| Losartan | 38 | $700 | $18 |
| Potassium Chloride | 18 | $687 | $38 |
| Allopurinol | 24 | $506 | $21 |
| Carvedilol | 19 | $459 | $24 |
| Metoprolol | 17 | $419 | $25 |
| Prednisone | 20 | $233 | $12 |
| Lisinopril | 20 | $197 | $10 |
| Ciprofloxacin | 18 | $159 | $9 |
| Hydrochlorothiazide | 26 | $72 | $3 |
2022: 24 drugs
| Sevelamer Carbonate | 60 | $23,041 | $384 |
| Veltassa | 23 | $18,776 | $816 |
| Midodrine | 38 | $2,948 | $78 |
| Calcium Acetate | 23 | $2,621 | $114 |
| Hydralazine | 82 | $2,163 | $26 |
| Calcitriol | 58 | $2,123 | $37 |
| Metolazone | 20 | $1,806 | $90 |
| Amlodipine Besylate | 94 | $1,132 | $12 |
| Bumetanide | 12 | $1,113 | $93 |
| Furosemide | 141 | $1,089 | $8 |
| Nifedipine Er | 12 | $1,025 | $85 |
| Losartan | 57 | $759 | $13 |
| Potassium Chloride | 27 | $633 | $23 |
| Allopurinol | 29 | $600 | $21 |
| Carvedilol | 28 | $443 | $16 |
| Metoprolol | 20 | $391 | $20 |
| Lidocaine-Prilocaine | 13 | $370 | $28 |
| Prednisone | 37 | $344 | $9 |
| Benazepril | 13 | $164 | $13 |
| Lisinopril | 26 | $145 | $6 |
| Hydrochlorothiazide | 21 | $142 | $7 |
| Ciprofloxacin | 30 | $127 | $4 |
| Vitamin D2 | 13 | $117 | $9 |
| Metoprolol | 11 | $57 | $5 |
2021: 22 drugs
| Jynarque | 13 | $212,553 | $16,350 |
| Sevelamer Carbonate | 59 | $22,340 | $379 |
| Veltassa | 13 | $12,106 | $931 |
| Calcium Acetate | 34 | $3,700 | $109 |
| Calcitriol | 57 | $1,892 | $33 |
| Nifedipine Er | 30 | $1,559 | $52 |
| Potassium Chloride | 21 | $1,299 | $62 |
| Metolazone | 15 | $1,204 | $80 |
| Hydralazine | 69 | $1,062 | $15 |
| Midodrine | 23 | $952 | $41 |
| Furosemide | 98 | $772 | $8 |
| Amlodipine Besylate | 68 | $755 | $11 |
| Losartan | 52 | $667 | $13 |
| Carvedilol | 37 | $445 | $12 |
| Torsemide | 15 | $429 | $29 |
| Allopurinol | 19 | $412 | $22 |
| Prednisone | 23 | $408 | $18 |
| Metoprolol | 13 | $265 | $20 |
| Tamsulosin | 13 | $203 | $16 |
| Hydrochlorothiazide | 21 | $107 | $5 |
| Lisinopril | 19 | $105 | $6 |
| Ciprofloxacin | 16 | $91 | $6 |
2020: 23 drugs
| Sevelamer Carbonate | 106 | $24,483 | $231 |
| Tacrolimus | 13 | $7,746 | $596 |
| Potassium Citrate Er | 24 | $3,567 | $149 |
| Calcium Acetate | 36 | $2,818 | $78 |
| Nifedipine Er | 36 | $1,749 | $49 |
| Losartan | 80 | $1,650 | $21 |
| Hydralazine | 52 | $1,220 | $23 |
| Calcitriol | 52 | $1,185 | $23 |
| Potassium Chloride | 15 | $913 | $61 |
| Midodrine | 14 | $862 | $62 |
| Furosemide | 103 | $805 | $8 |
| Amlodipine Besylate | 83 | $688 | $8 |
| Prednisone | 44 | $656 | $15 |
| Metoprolol | 22 | $497 | $23 |
| Torsemide | 25 | $451 | $18 |
| Allopurinol | 23 | $395 | $17 |
| Carvedilol | 33 | $337 | $10 |
| Metoprolol | 32 | $238 | $7 |
| Lisinopril | 35 | $221 | $6 |
| Doxazosin Mesylate | 11 | $179 | $16 |
| Clonidine | 13 | $170 | $13 |
| Hydrochlorothiazide | 19 | $80 | $4 |
| Cephalexin | 11 | $43 | $4 |
2019: 29 drugs
| Renvela | 22 | $35,786 | $1,627 |
| Sevelamer Carbonate | 57 | $21,055 | $369 |
| Nifedipine Er | 48 | $3,204 | $67 |
| Metolazone | 15 | $1,222 | $81 |
| Losartan | 89 | $1,102 | $12 |
| Calcium Acetate | 11 | $897 | $82 |
| Calcitriol | 32 | $863 | $27 |
| Amlodipine Besylate | 117 | $852 | $7 |
| Potassium Chloride | 22 | $842 | $38 |
| Furosemide | 119 | $800 | $7 |
| Hydralazine | 34 | $765 | $23 |
| Carvedilol | 77 | $702 | $9 |
| Prednisone | 52 | $654 | $13 |
| Tamsulosin | 34 | $522 | $15 |
| Lidocaine-Prilocaine | 12 | $391 | $33 |
| Lisinopril | 30 | $381 | $13 |
| Pantoprazole | 26 | $373 | $14 |
| Torsemide | 16 | $349 | $22 |
| Metoprolol | 32 | $343 | $11 |
| Allopurinol | 17 | $274 | $16 |
| Metoprolol | 14 | $246 | $18 |
| Sulfamethoxazole-Trimethoprim | 33 | $245 | $7 |
| Clonidine | 15 | $193 | $13 |
| Atorvastatin | 14 | $185 | $13 |
| Famotidine | 27 | $158 | $6 |
| Pravastatin | 11 | $126 | $11 |
| Benazepril | 11 | $123 | $11 |
| Ranitidine | 11 | $55 | $5 |
| Hydrochlorothiazide | 14 | $41 | $3 |
2018: 27 drugs
| Valganciclovir | 69 | $52,248 | $757 |
| Sensipar | 25 | $35,312 | $1,412 |
| Eliquis | 21 | $8,880 | $423 |
| Uloric | 13 | $6,524 | $502 |
| Nifedipine Er | 83 | $6,300 | $76 |
| Hydralazine | 46 | $1,361 | $30 |
| Nystatin | 14 | $1,240 | $89 |
| Carvedilol | 170 | $1,200 | $7 |
| Sulfamethoxazole-Trimethoprim | 130 | $846 | $7 |
| Prednisone | 61 | $812 | $13 |
| Losartan | 87 | $642 | $7 |
| Rosuvastatin | 13 | $591 | $45 |
| Tamsulosin | 35 | $566 | $16 |
| Metoprolol | 16 | $506 | $32 |
| Famotidine | 65 | $437 | $7 |
| Atorvastatin | 24 | $323 | $13 |
| Metoprolol | 46 | $314 | $7 |
| Insulin | 11 | $284 | $26 |
| Furosemide | 59 | $274 | $5 |
| Clonidine | 29 | $254 | $9 |
| Pantoprazole | 25 | $234 | $9 |
| Allopurinol | 22 | $219 | $10 |
| Duloxetine | 11 | $196 | $18 |
| Amlodipine Besylate | 22 | $181 | $8 |
| Lisinopril | 17 | $177 | $10 |
| Clopidogrel | 12 | $147 | $12 |
| Acetaminophen-Codeine | 11 | $73 | $7 |
2017: 28 drugs
| Valganciclovir | 93 | $118,166 | $1,271 |
| Sensipar | 27 | $42,439 | $1,572 |
| Nifedipine Er | 114 | $5,023 | $44 |
| Mycophenolate Mofetil | 11 | $2,613 | $238 |
| Sulfamethoxazole-Trimethoprim | 203 | $1,452 | $7 |
| Carvedilol | 179 | $1,096 | $6 |
| Clotrimazole | 16 | $990 | $62 |
| Losartan | 98 | $836 | $9 |
| Prednisone | 51 | $705 | $14 |
| Metolazone | 13 | $599 | $46 |
| Tamsulosin | 31 | $560 | $18 |
| Famotidine | 123 | $549 | $4 |
| Fluconazole | 13 | $515 | $40 |
| Hydralazine | 28 | $487 | $17 |
| Clonidine | 38 | $326 | $9 |
| Ciprofloxacin | 26 | $302 | $12 |
| Pantoprazole | 40 | $278 | $7 |
| Doxazosin Mesylate | 18 | $267 | $15 |
| Furosemide | 55 | $247 | $4 |
| Potassium Chloride | 16 | $244 | $15 |
| Metoprolol | 49 | $204 | $4 |
| Amlodipine Besylate | 33 | $164 | $5 |
| Warfarin | 15 | $159 | $11 |
| Atorvastatin | 21 | $122 | $6 |
| Lisinopril | 23 | $118 | $5 |
| Acetaminophen-Codeine | 19 | $111 | $6 |
| Ranitidine | 16 | $74 | $5 |
| Gabapentin | 11 | $33 | $3 |
2016: 22 drugs
| Valganciclovir | 59 | $95,797 | $1,624 |
| Sensipar | 39 | $47,284 | $1,212 |
| Nifedipine Er | 50 | $3,381 | $68 |
| Sulfamethoxazole-Trimethoprim | 128 | $851 | $7 |
| Clotrimazole | 12 | $739 | $62 |
| Prednisone | 50 | $641 | $13 |
| Nifedical Xl | 21 | $486 | $23 |
| Atorvastatin | 23 | $482 | $21 |
| Losartan | 70 | $481 | $7 |
| Tamsulosin | 17 | $364 | $21 |
| Famotidine | 72 | $345 | $5 |
| Carvedilol | 64 | $320 | $5 |
| Doxazosin Mesylate | 11 | $242 | $22 |
| Hydralazine | 17 | $238 | $14 |
| Clonidine | 26 | $230 | $9 |
| Metoprolol | 33 | $180 | $5 |
| Ciprofloxacin | 20 | $165 | $8 |
| Amlodipine Besylate | 26 | $153 | $6 |
| Furosemide | 27 | $145 | $5 |
| Acetaminophen-Codeine | 18 | $103 | $6 |
| Pantoprazole | 17 | $99 | $6 |
| Lisinopril | 16 | $74 | $5 |
2015: 12 drugs
| Valganciclovir | 33 | $42,561 | $1,290 |
| Sensipar | 13 | $17,403 | $1,339 |
| Nifedipine Er | 37 | $3,004 | $81 |
| Sulfamethoxazole-Trimethoprim | 40 | $192 | $5 |
| Prednisone | 13 | $165 | $13 |
| Atorvastatin | 15 | $143 | $10 |
| Amlodipine Besylate | 23 | $131 | $6 |
| Famotidine | 29 | $130 | $4 |
| Losartan | 28 | $124 | $4 |
| Carvedilol | 24 | $124 | $5 |
| Furosemide | 24 | $90 | $4 |
| Ciprofloxacin | 12 | $68 | $6 |
Money from drug and device companies
$43 in 2025
| 2025 | 1 | 3 | None | $43 |
| 2024 | 1 | 2 | None | $6 |
| 2023 | 4 | 7 | None | $147 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Travere Therapeutics | Filspari | $43 | 3 payments
|
See all 3 published payments
| Travere Therapeutics | Meals · 2025-09-03 | None | $15 |
| Travere Therapeutics | Meals · 2025-08-12 | None | $6 |
| Travere Therapeutics | Meals · 2025-06-09 | Filspari | $22 |
See earlier years (2024, 2023)
2024: $6
| Travere Therapeutics | None | $6 | 2 payments
|
2023: $147
| Vifor Pharma | Veltassa | $51 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $47 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $27 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $21 | 1 payment
|
Professional record
- NPI
- 1437380987
- Licence
- CA C157688, TX P8761California C157688: Current · expires 2028-08-31Texas P8761: Active
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2301 Circadian Way Ste A, Santa Rosa, CA, 95407
- NPI first listed
- 2009-07-31
- NPI last updated
- 2026-06-22
- NPI record certified
- 2026-06-22
This is when the NPI record was last certified, not a medical board exam.